Diabetic Retinopathy study: PRONTO-EYE
Official title Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
ClinicalTrials.gov ID: NCT07296952
What this study is testing
- What it's testing
- The study wants to find out if giving rideshare transportation improves how often these patients attend their ophthalmology visits.
- Who it's for
- People with diabetic retinopathy who are covered by Medicaid.
- What's involved
- Participants will be offered rideshare rides to their eye appointments, and the research team will track appointment attendance and may ask a few survey questions.
- Time commitment
- The pilot runs for the length of the study period, with transportation arranged for each scheduled eye visit and no extra study visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Established patient
- Medicaid insurance
- History of diabetic retinopathy
- Lives within 25 miles of the clinic
- English speaking
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Compensation & support
Travel help or reimbursement may be available.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you, and this study mentions travel support. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.